GLP1R and atrial fibrillation: According to Loryn J et al.’s animal model, GLP-1 treatment in type 2 diabetic mice could prevent atrial conduction impairment, electrical remodeling, and fibrosis, thereby reducing the risk of atrial fibrillation [61].